Literature DB >> 23166341

Long-term complications of therapeutic exposures in childhood: lessons learned from childhood cancer survivors.

Smita Bhatia1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23166341      PMCID： PMC3507259          DOI： 10.1542/peds.2012-2884

Source DB:  PubMed          Journal:  Pediatrics        ISSN： 0031-4005            Impact factor:   7.124


× No keyword cloud information.
  23 in total

Review 1.  Nontraumatic necrosis of bone (osteonecrosis).

Authors:  H J Mankin
Journal:  N Engl J Med       Date:  1992-05-28       Impact factor: 91.245

2.  The relationship of gonadal activity and chemotherapy-induced gonadal damage.

Authors:  S A Rivkees; J D Crawford
Journal:  JAMA       Date:  1988-04-08       Impact factor: 56.272

3.  The effect of testicular x-irradiation on spermatogenesis in man. A comparison with the mouse.

Authors:  D K Clifton; W J Bremner
Journal:  J Androl       Date:  1983 Nov-Dec

4.  Anthracycline-related cardiomyopathy after childhood cancer: role of polymorphisms in carbonyl reductase genes--a report from the Children's Oncology Group.

Authors:  Javier G Blanco; Can-Lan Sun; Wendy Landier; Lu Chen; Diego Esparza-Duran; Wendy Leisenring; Allison Mays; Debra L Friedman; Jill P Ginsberg; Melissa M Hudson; Joseph P Neglia; Kevin C Oeffinger; A Kim Ritchey; Doojduen Villaluna; Mary V Relling; Smita Bhatia
Journal:  J Clin Oncol       Date:  2011-11-28       Impact factor: 44.544

5.  Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group.

Authors:  L A Mattano; H N Sather; M E Trigg; J B Nachman
Journal:  J Clin Oncol       Date:  2000-09-15       Impact factor: 44.544

Review 6.  Radiation-induced and chemotherapy-induced pulmonary injury.

Authors:  S H Abid; V Malhotra; M C Perry
Journal:  Curr Opin Oncol       Date:  2001-07       Impact factor: 3.645

Review 7.  Frequency and risk factors of anthracycline-induced clinical heart failure in children: a systematic review.

Authors:  L C M Kremer; E C van Dalen; M Offringa; P A Voûte
Journal:  Ann Oncol       Date:  2002-04       Impact factor: 32.976

8.  High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the Late Effects Study Group.

Authors:  Smita Bhatia; Yutaka Yasui; Leslie L Robison; Jillian M Birch; Monica K Bogue; Lisa Diller; Cyndi DeLaat; Franca Fossati-Bellani; Elaine Morgan; Odile Oberlin; Gregory Reaman; Frederick B Ruymann; Jean Tersak; Anna T Meadows
Journal:  J Clin Oncol       Date:  2003-12-01       Impact factor: 44.544

9.  Abnormalities of the thyroid in survivors of Hodgkin's disease: data from the Childhood Cancer Survivor Study.

Authors:  C Sklar; J Whitton; A Mertens; M Stovall; D Green; N Marina; B Greffe; S Wolden; L Robison
Journal:  J Clin Endocrinol Metab       Date:  2000-09       Impact factor: 6.134

10.  Final height and body mass index among adult survivors of childhood brain cancer: childhood cancer survivor study.

Authors:  James G Gurney; Kirsten K Ness; Marilyn Stovall; Suzanne Wolden; Judy A Punyko; Joseph P Neglia; Ann C Mertens; Roger J Packer; Leslie L Robison; Charles A Sklar
Journal:  J Clin Endocrinol Metab       Date:  2003-10       Impact factor: 6.134
View more
  5 in total

1.  Etoposide-loaded immunoliposomes as active targeting agents for GD2-positive malignancies.

Authors:  Brandon S Brown; Tariq Patanam; Keyan Mobli; Christian Celia; Peter E Zage; Andrew J Bean; Ennio Tasciotti
Journal:  Cancer Biol Ther       Date:  2014-04-22       Impact factor: 4.742

2.  Chronic condition clusters and functional impairment in older cancer survivors: a population-based study.

Authors:  Kelly M Kenzik; Erin E Kent; Michelle Y Martin; Smita Bhatia; Maria Pisu
Journal:  J Cancer Surviv       Date:  2016-05-27       Impact factor: 4.442

Review 3.  Imaging of late complications of cancer therapy in children.

Authors:  Susan C Shelmerdine; Govind B Chavhan; Paul S Babyn; Paul C Nathan; Sue C Kaste
Journal:  Pediatr Radiol       Date:  2016-12-01

4.  Hepatic late adverse effects after antineoplastic treatment for childhood cancer.

Authors:  Renée L Mulder; Dorine Bresters; Malon Van den Hof; Bart Gp Koot; Sharon M Castellino; Yoon Kong K Loke; Piet N Post; Aleida Postma; László P Szőnyi; Gill A Levitt; Edit Bardi; Roderick Skinner; Elvira C van Dalen
Journal:  Cochrane Database Syst Rev       Date:  2019-04-15

5.  Somatic inactivation of Tp53 in hematopoietic stem cells or thymocytes predisposes mice to thymic lymphomas with clonal translocations.

Authors:  Amy DeMicco; Katherine Yang-Iott; Craig H Bassing
Journal:  Cell Cycle       Date:  2013-09-09       Impact factor: 4.534
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.